Evidence map›Paper›PMID 31131229›Full record

ArticleInternational journal of ophthalmology2019

A novel mutation in

Ping-Bo Ouyang, Yuan Zhao, Ying-Qian Peng, Lu-Si Zhang, Jian Cao, Yun Li

Open access · goldAbstract read
In one paragraph

Article in International journal of ophthalmology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. A novel missense variant ofFrontiers in pediatrics · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ping-Bo OuyangDepartment of Ophthalmology, the Second Xiangya Hospital of Central South University, Changsha 410011, Hunan Province, China.
Yuan ZhaoDepartment of Cardiovascular Surgery, the Second Xiangya Hospital of Central South University, Changsha 410011, Hunan Province, China.
Ying-Qian PengDepartment of Ophthalmology, the Second Xiangya Hospital of Central South University, Changsha 410011, Hunan Province, China.
Lu-Si ZhangDepartment of Ophthalmology, the Second Xiangya Hospital of Central South University, Changsha 410011, Hunan Province, China.
Jian CaoDepartment of Ophthalmology, the Second Xiangya Hospital of Central South University, Changsha 410011, Hunan Province, China.
Yun LiDepartment of Ophthalmology, the Second Xiangya Hospital of Central South University, Changsha 410011, Hunan Province, China.
Second Xiangya Hospital of Central South University · CNCentral South University · CNHunan Provincial Center for Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo report a novel mutation in

methodsOphthalmic, cardiovascular and systemic examinations were performed, and genomic DNA extracted from all living family members. The 24-32 exon mutations of

resultsIn the four-generation family, classic MFS phenotypes were observed in all 5 patients, 2 of them had peculiar phenotype of bilateral macular degeneration. Mutation screening in

conclusionA Chinese consanguineous MFS family with uncommon bilateral macular degeneration and an unreported c.3932A>G mutation in

Indexed as

autosomal dominantfibrillin-1heterozygous mutationMarfan syndrome

Identifiers

PMID31131229
PMCPMC6520272
OpenAlexW2948020686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.